title: [The use of endobronchial aztreonam in the treatment of bronchiectatic suppuration].
abstract: The authors submitted 8 patients with bronchiectasis to endobronchial therapy with Aztreonam 2 gr twice a week for 4 weeks after endobronchial lavage with sodium chloride solution. They observed a definite clinical and radiological improvement and a stabilized condition of the disease was observed. No hepatic or renal toxicity was detected.
authors: Università degli Studi di Roma La Sapienza.
authors: M
authors: M
authors: Matzeu
authors: G
authors: G
authors: Failla
authors: A
authors: A
authors: Bolzan Mariotti
authors: M
authors: M
authors: Mosillo
authors: F
authors: F
authors: Lavorgna
mesh_terms: D000328:Adult; D000368:Aged; D001398:Aztreonam / Q000008:administration & dosage*; D001980:Bronchi; D001987:Bronchiectasis / Q000150:complications* / Q000188:drug therapy; D001999:Bronchoscopy; D002908:Chronic Disease; D004341:Drug Evaluation; D005260:Female; D005336:Fiber Optic Technology; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D008875:Middle Aged; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000209:etiology
chemical_list: D001398:Aztreonam
vernacular_title: Impiego dell'aztreonam per via endobronchiale nel trattamento delle suppurazioni bronchiectasiche.